Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Fluid retention
ADR ID BADD_A01668
ADR Hierarchy
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.06      Total fluid volume increased
14.05.06.002      Fluid retention
20      Renal and urinary disorders
20.01      Renal disorders (excl nephropathies)
20.01.02      Renal disorders NEC
20.01.02.003      Fluid retention
Description Not Available
MedDRA Code 10016807
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Body fluid retention | Extracellular fluid increased | Fluid retention | Fluid retention in tissues | Free water clearance decreased | Idiopathic fluid retention | Interstitial fluid increased | Retention water | Tissue fluid increased | Water retention | Water retention in tissues | Water retention of
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02274Triamcinolone hexacetonide--
BADD_D02299Trisequens--
BADD_D02305Trospium--
BADD_D02312Ulipristal--
BADD_D02321Ursodiol--
BADD_D02325Valdecoxib--
BADD_D02367Voltaren--
BADD_D02379Zaleplon--
BADD_D02383Zidovudine--
BADD_D02412Octreotide0.000373%
BADD_D02445Solifenacin0.000851%
BADD_D02453Midostaurin0.000381%
BADD_D02464Fingolimod--
BADD_D02470Nintedanib--
BADD_D02473Sodium chloride--
BADD_D02480Alectinib--
BADD_D02482Acalabrutinib0.000168%
BADD_D02483Ribociclib--
BADD_D02489Neratinib0.000246%
BADD_D02492Deflazacort0.000209%
BADD_D02498Abemaciclib--
BADD_D02499Fostamatinib0.001166%
BADD_D02504Lorlatinib0.000604%
BADD_D02510Rucaparib0.000828%
BADD_D02511Siponimod--
BADD_D02515Pexidartinib0.000381%
BADD_D02517Enasidenib0.000381%
BADD_D02521Sodium zirconium cyclosilicate0.004833%
BADD_D02524Ivosidenib0.000492%
BADD_D02526Larotrectinib0.000112%
The 9th Page    First    Pre   9 10    Next   Last    Total 10 Pages